Skip to main content

Take control of preoperative nasal decolonization

3M™ Skin and Nasal Antiseptic (Povidone-Iodone Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation is designed to reduce bacteria in the nares prior to surgery and help reduce risks of surgical site infections (SSIs)

 

 

Skin and Nasal Antiseptic Bottle and Applicators, white background, product photo, cmyk, tiff, 70-2010-8268-5, 70-2010-8271-9, 70-2010-8272-7, 70-2010-8274-3, 70-2010-8275-0, 70-2010-8277-6, 70-2010-8278-4, 70-2010-8380-8, 70-2010-8378-2, 70-2010-8379-0, 70-2010-8375-8, 70-2010-8374-1, 70-2010-8399-8

Enhance patient safety in the ICU and the OR

Nurse swabbing female patient's nose. Skin and nasal image.

Make Skin and Nasal Antiseptic part of your nasal decolonization protocol

 

Confidence in surgery matters. Take control of your patients’ nasal decolonization in both the intensive care unit (ICU) and operating room (OR) with Skin and Nasal Antiseptic.


 

Designed to help address the rising concern of SSIs that can be caused by bacteria in the nares, this solution is a key element of patient preoperative skin preparation. By reducing the risk factors that contribute to SSIs, you can make a significant impact on patient outcomes. Using Skin and Nasal Antiseptic before surgery and in the ICU helps reduce bacterial load, including Staphylococcus aureus, which is the leading cause of SSIs among adult and pediatric patients. By aligning with CDC, SHEA, IDSA, APIC and other leading organizations, you can help prevent SSIs.


 

We share your passion for infection prevention. Let us help you protect every patient, every time.

 

Proven efficacy. Simple application

Make a real difference in your presurgical infection prevention protocol with Skin and Nasal Antiseptic (Povidone-Iodine Solution 5% w/w [0.5% available iodine] USP) Patient Preoperative Skin Preparation. Designed to prepare the skin prior to surgery and help reduce bacteria that potentially can cause skin infection. 

 

  • Simple, one-time application 
  • Helps reduce bacteria that potentially can cause skin infections 
  • 99.9% decrease in bacteria within 10 minutes and sustained reduction for up to 6 hours
  • Kills mupirocin non-susceptible MRSA and vancomycin-intermediate MRSA1 *  

Strength of our antiseptics

Improves patient safety and protocol compliance without antibiotics.²

Zero S. aureus infection in per protocol analysis with 3M Skin and Nasal Antiseptic, compared to mupirocin.²

An iconographic representation of a sick patient paired with a representation of bacteria. Dark green and medium teal positive color palette.

Unique film-forming polymer increases persistence. 

An iconographic representation of a checkmark within a circle centered inside of a larger circle with three smaller circles placed on top to represent collaboration. Dark green and teal positive color palette.

*When evaluated using an in vitro test method. The clinical significance of in vitro data is unknown. 

Why choose Skin and Nasal Antiseptic?

10+ years since initial launch

Our Skin and Nasal Antiseptic is supported by evidence that met or exceeded the hypotheses across multiple endpoints including microbiological impacts that were associated with infection risk reduction outcomes and economic success when used as part of a comprehensive perioperative solution. 

Unique Formulation

 

Iodine is rapidly reduced to inactive iodide at the normal pH of the nose (5.5-6.5). Skin and Nasal Antiseptic is specially formulated with a buffer to maintain a pH less than 4.5 to maintain the active iodine3

Driven by evidence


 

The nasal antiseptic that has been extensively researched and supported by over 10 clinical studies (7 peer reviewed and 10+ investigator initiated) — more than any other nasal decolonization competitor.

Greater MRSA log reduction⁴

 

Skin and Nasal Antiseptic showed significantly more persistent antiseptic activity against MRSA at every interval compared to 10% Betadine®, Povidone Iodine Nasal Antiseptic Swabs – Medline®, or Profend® Nasal Decolonization Kit (ex vivo test model).*

Age acceptability


 

Skin and Nasal Antiseptic can be used on patients as young as 2 months of age.5

Choose our evidence-based antiseptic nasal swabs as part of your nasal decolonization protocol to prepare the skin prior to surgery and help reduce bacteria that potentially can cause skin infections.

*(Ex vivo porcine model): Anderson M, David M et al. 2015. Efficacy of Skin and Nasal Povidone-Iodine Preparation against mupirocin resistant MRSA and Staphylococcus aureus with the anterior nares, Antimicrob Agents Chemother. pii: AAC.04624-14.

3M Peak Decolonization

Our decolonization assessment program analyzes current practices at your facility, enabling you to implement evidence-based protocols that reduce the risk of SSIs and enhance surgical outcomes.

A medical doctor and nurse discussing a patient chart.

Contact a Solventum representative

We're here to help! Our team of representatives can provide you with information and resources to help you. Submit the form below to speak with a Solventum representative to learn more about your options.

Looking for customer support? Visit the customer support page.

Fields marked with an * are required.

 

Solventum will use the information to respond to your request in accordance with our Privacy Policy

References:

  1. Karau M, Ballard A et al. “3M Skin and Nasal Antiseptic and 3M DuraPrep Surgical Solution Bactericidal Activity Against Methicillin-Resistant Staphylococcus aureus.” American Society for Microbiology General Meeting, Boston MS, May 2014.
  2. Phillips M, Rosenberg A, Shopsin B, et al. Preventing surgical site infections: A randomized, open-label trial of nasal mup. ointment and nasal povidone-iodine solution. Infect Control Hosp Epidemiol. 2014;35:826-32.
  3. 3M data on file: EM-05-011017.
  4. 3M data on file. 
  5. 3M data on file: EM-05-159073.